Cac 40: Sanofi resists but the CAC 40 falls below 7,300 points


(BFM Bourse) – The Paris Stock Exchange begins this week on a downward trend, before the publication of numerous data relating to prices over the coming days.

A breather before the big jump? The Paris Stock Exchange is delaying at the start of a busy week of major macroeconomic meetings, and particularly on the inflation front.

Germany on Wednesday, then France and the euro zone on Thursday will publish the first estimate of inflation for the month of November. In the United States, the PCE index, the preferred gauge of the American Federal Reserve (Fed), will also be published on Thursday.

This Monday, November 27, the CAC 40 fell by 0.37% to return below 7,300 points, to 7,265.49 points this Monday evening. On Friday, the flagship Parisian index gained 0.8% over the whole of a week marked by the absence of American benchmarks at the end of last week (Thanksgiving on Thursday and a shortened session on Friday on Wall Street).

Elior supported by Deutsche Bank

On the value side, Elior only gained 1.4% at the close. Deutsche Bank raised its recommendation to buy on the stock. The financial intermediary is convinced by the emphasis placed on debt reduction by the Derichebourg family as well as by the low valuation of the stock.

Sanofi limits its advance to 0.3% this Monday evening, after the announcement of encouraging results from clinical trials for its blockbuster Dupixent in the treatment of the disease known as “smoker’s lung”. The group has indicated that it wants to submit a marketing application in the United States for this indication by the end of the year. Bank of America welcomes “very robust” data.

While Valneva, up most of the session, turned downward (-0.4%) despite a new step for its vaccine candidate against chikungunya on European soil.

Groupe ADP lost 1.3%, penalized by seemingly unjustified concerns about the regulation of French airports.

Atos fell 10.1% as BFM Business reported that the group could take various measures as part of its financial restructuring. The company could in particular ask Daniel Kretinsky to increase the cash disbursed by the Czech businessman to buy its outsourcing activities and, in return, Daniel Kretinsky would ultimately not enter into the capital of Eviden, the future “new Atos”, refocused on its growing businesses.

On other markets, the euro lost 0.06% against the dollar to 1.0933 dollars. Oil is falling. The January contract on North Sea Brent fell 0.4% to $80.15 per barrel while that of the same maturity on WTI listed in New York also lost 0.4% to $75.23 per barrel.

Sabrina Sadgui – ©2023 BFM Bourse



Source link -84